Capsules
Black Week
20% off everything with code BLACK
Click and the code is added to your cart.
Until Monday 30 Nov, 23:59 (Polish time).
Black Friday
20% off everything with code BLACK
Click and the code is added to your cart.
Until Monday 30 Nov, 23:59 (Polish time).
Last day
20% off everything with code BLACK
The code works until 23:59 today (Polish time).
Other categories
13 products
-
'/%3E%3C/svg%3E)
-
-
-
-
-
-
-
-
S-23 60 caps S-23 60 caps47,99 €
-
S4 60 caps S4 60 caps37,99 €
-
-
-
Black Week
Black Week deals before everyone else
Sign up for the newsletter and get access to the Black Week promotion before other customers.
By signing up you agree to receive the Pro-Body newsletter with news and promotions. You can unsubscribe at any time with one click in the e-mail. Privacy policy
SARMs in capsules - research reagents
What places an item in this category is its form: a capsule with a standardised, declared compound content. That value states how much substance one unit of material contains; it is not a recommended amount or a dose. Research Use Only principles apply.
The capsules include SARMs (selective androgen receptor modulators) and, alongside them, compounds with an entirely different mechanism: a growth hormone secretagogue and a metabolic receptor agonist. A shared form does not mean a shared mechanism, regulatory status or research direction. All of that is determined by the compound.
Characteristics of the form
A capsule is a solid reagent form with a standardised molecule content. The content is uniform within a batch, which can be convenient when working with repeatable portions of research material. The dry form also helps storage stability.
SARMs in capsules
The androgen receptor modulators available in this form include Ostarine MK-2866, LGD-4033 (Ligandrol) and RAD-140 (Testolone). All of them act through the androgen receptor with tissue preference and appear on the WADA Prohibited List in section S1.2.
Non-SARM modulators in capsules
The same form also includes compounds that are not SARMs. MK-677 (Ibutamoren) is a growth hormone secretagogue acting through the ghrelin receptor (GHS-R), and GW-501516 (Cardarine) is a PPARδ receptor agonist. They differ from AR modulators in both mechanism and WADA code.
Regulatory status
Regulatory status follows from the molecule. The SARMs (Ostarine, LGD-4033, RAD-140) appear on the WADA Prohibited List in section S1.2 (other anabolic agents). The other compounds have separate codes: MK-677, as a GH secretagogue, falls under section S2 (peptide hormones, growth factors and mimetics), and Cardarine (GW-501516), as a PPARδ agonist, under section S4.4 (metabolic modulators). An athlete registered in the ADAMS system must check the current list before any decision. None of these reagents is authorised as a medicine.
Applications in scientific research
The compounds grouped in this form serve different research questions. The category gives no doses or cycles, and the researcher prepares working solutions from the capsules. The main directions:
- Androgen receptor pharmacology: tissue profile and functional selectivity of SARMs in recombinant expression systems
- GH/IGF-1 axis signalling: ghrelin receptor secretagogues (MK-677) in growth hormone release models
- Lipid metabolism and PPARδ signalling: PPARδ agonists (Cardarine) in fatty acid oxidation models
- Batch uniformity and identity: verifying the declared content, HPLC purity and compound identity in the COA
- Comparative models: comparing the profiles of different modulator classes available in the same form
Scientific perspective
The observations attributed to these compounds come from cellular and animal models and, for some molecules, from early-phase studies. The strength and nature of the activity are set by the molecule and the model. The capsule describes only the form of the material.
Important distinction
A capsule is a form, not a compound class, and it says nothing about activity. The identity of the material is decided by the structure and mass confirmed in the batch COA, not by the trade name. Promises of physique effects are contrary to RUO principles.
Working with this form
- The content per capsule is declared and standardised within the batch
- The uniformity of the material makes it easier to take repeatable portions in a laboratory protocol
- For a working solution, the researcher chooses the solvent and concentration according to the methodology. The category gives neither of these parameters
- Storage in line with the batch label
The same compounds in ready-solution form are collected in the SARMs – liquid category. You will find the full list of AR modulators and related compounds in the parent SARMs category.
Frequently asked questions (FAQ)
Is the declared content per capsule a recommended amount?
No. The value states how much substance one unit of research material contains; it is not a recommended amount or a dose. This is an RUO reagent with no application outside the laboratory.
Are all the capsules in this category SARMs?
No. Alongside the AR modulators (Ostarine, LGD-4033, RAD-140), there are two compounds from outside this group: MK-677 (GH secretagogue, WADA S2) and Cardarine GW-501516 (PPARδ agonist, WADA S4.4). They differ in mechanism and status; only the form is shared.
Does the capsule form change a compound’s WADA status?
No. Regulatory status follows from the molecule, so the form does not change it. SARMs remain in section S1.2, MK-677 in S2 and Cardarine in S4.4, including when the same compound comes as a solution.
How can a compound’s identity and content be confirmed?
Through the batch certificate of analysis (COA). In it, mass spectrometry confirms structure and mass, purity is determined by HPLC and analysis verifies the declared content. The trade name does not settle the molecule’s identity.